| 000 | 01859cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030621.0 | ||
| 008 | 120510s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.12.21.M.Sc.2011.Sa.E | ||
| 100 | 0 | _aSafinaz Ali Elshabrawy Elsaied | |
| 245 | 1 | 0 |
_aEvaluation of C - reactive protein as a probable factor for cancer diagnosis / _cSafinaz Ali Elshabrawy Elsaied ; Supervised Somaya Osman Eldeeb , Ahmed M. A. Osman , Mohamed A. Elbeddini |
| 246 | 1 | 5 | _aتقييم البروتين المتفاعل سى كعامل محتمل لتشخيص السرطان |
| 260 |
_aCairo : _bSafinaz Ali Elshabrawy Elsaied , _c2011 |
||
| 300 |
_a131 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Science - Department of Zoology | ||
| 520 | _aC - reactive protein ( CRP ) is a definitive marker of inflammation produced and synthesized in the liver in response of interleukin - 6 ( IL - 6 ) and some other cytokines . CRP was studied in 10 healthy individuals and 97 patients with different typs of diseases including kidney failure ( KF ) , cardiovascular disease ( CVD ) , hepatocellular carcinoma ( HCC ) , Non - Hodgkin lymphoma (NHL ) , lung cancer ( L. C ) , colon and bladder carcinoma ( C. C ) , ovary and cervix carcinoma ( O . C ) and brest cancer ( B . C ) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute phase proteins | |
| 653 | 4 | _aC - reactive protein | |
| 653 | 4 | _aInflammation | |
| 700 | 0 |
_aAhmed M. A. Osman , _eSupervisor |
|
| 700 | 0 |
_aMohamed A. Elbeddini , _eSupervisor |
|
| 700 | 0 |
_aSomaya Osman Eldeeb , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c38439 _d38439 |
||